Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 26, 2023 10:17 ET | Source: Moore Kuehn

Moore Kuehn Encourages AMNB, SCU, NLTX, and PRDS Investors to Contact Law Firm

NEW YORK, July 26, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...
November 12, 2021 14:20 ET | Source: ImCheck Therapeutics SAS

ImCheck Provides Promising Updated Patient Response Data from the Phase I/IIa EVICTION Trial with ICT01 at SITC Meeting 2021

Oral presentation includes positive safety data across a wide range of ICT01 doses and efficacy data from patients receiving ICT01 plus pembrolizumab confirming durable clinical responses at low ICT01...
August 09, 2019 08:00 ET | Source: Aquinox Pharmaceuticals, Inc.

Neoleukin Therapeutics and Aquinox Pharmaceuticals Complete Merger Transaction

Nasdaq Ticker Symbol “NLTX” to be effective Monday, August 12, 2019 SEATTLE, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc. (“Neoleukin”), a biopharmaceutical company...
August 06, 2019 07:00 ET | Source: Aquinox Pharmaceuticals, Inc.

Aquinox Pharmaceuticals and Neoleukin Therapeutics announce merger agreement

• Combined company capitalized with approximately $65M to develop novel immunotherapies • Sophisticated computational platform enables new class of de novo protein therapeutics • Lead program,...